Clario delivers substantial gains toward diversity and net-zero emission goals in second annual ESG report

Notable highlights from the report include: Notable highlights from the report include: "We firmly believe in the power of diversity as a driving force behind our continuous improvement in performance and innovation," saidDavid Fusco, Chief Human Capital Officer at Clario. "It is also behind our success in delivering on our environmental and governance commitments. For us, we see diversity and inclusion as a means to enhance our ability to serve our customers better and drive positive...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Notable highlights from the report include:

"We firmly believe in the power of diversity as a driving force behind our continuous improvement in performance and innovation," said David Fusco, Chief Human Capital Officer at Clario. "It is also behind our success in delivering on our environmental and governance commitments. For us, we see diversity and inclusion as a means to enhance our ability to serve our customers better and drive positive change."

To access Clario's second annual Environmental, Social, and Governance (ESG) report, go to Clario.com.

Contact Information
Duncan Cantor
Sr. Director, Corporate Communications
media@clario.com

Clario delivers substantial gains toward diversity and net-zero emission goals in second annual ESG report

About Clario
Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With 11 facilities in six countries, Clario's global team of science, technology and operational experts has helped deliver over 27,000 trials and more than 500 regulatory approvals since 2012 for over five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.

For more information, go to Clario.com or follow us on LinkedIn and Twitter.

Logo - https://mma.prnewswire.com/media/1677749/Clario_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/clario-delivers-substantial-gains-toward-diversity-and-net-zero-emission-goals-in-second-annual-esg-report-302010545.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;